Health ❯ Healthcare

Pharmaceuticals

Drug Development Drug Approval Drug Safety Clinical Trials Drug Pricing Weight Loss Cancer Treatment Drug Regulation Medications Weight Loss Drugs

3 ARTICLES

2d ago

INmune Bio and Quantum Computing Inc. Team Up to Run XPro Data Through a Quantum Optimizer

The partnership will use QCi’s Dirac-3S with AI and standard analytics to search for new disease uses and predictive biomarkers for XPro and to test whether the quantum approach adds practical value.

10 ARTICLES

2d ago

Amazon-Brand Acetaminophen Recalled After Reports of Discolored Tablets

6 ARTICLES

last wk.

Cochrane Review Finds Pharma Gifts and Payments Drive More and Less Appropriate Prescribing

36 ARTICLES

last wk.

Controlled Study Finds Higher Rates of Nail Detachment and Hair Loss in GLP‑1 Users

3 ARTICLES

2w ago

AstraZeneca, Daiichi Sankyo and Summit Launch Global Trials of Datroway With Ivonescimab

3 ARTICLES

2w ago

Journal Review Highlights Ecopipam as a Non‑Antipsychotic Option for Pediatric Tourette

3 ARTICLES

2w ago

Postpartum GLP‑1 Starts Surge in U.S., Rising More Than 20‑Fold by Early 2025

5 ARTICLES

2w ago

Sanofi Expands Regeneron Collaboration With $1 Billion Upfront for Four Antibody Programs

40 ARTICLES

2w ago

Retatrutide Drives Record Weight Loss in Type 2 Diabetes, Company Moves Toward U.S. Filing

4 ARTICLES

2w ago

Orforglipron Found Noninferior to Insulin Glargine for Major Heart Events

4 ARTICLES

2w ago

U.S. Spending on GLP‑1 Drugs Rises to $64.9 Billion as Patient Costs Bite

7 ARTICLES

2w ago

Cofepris Issues Alert for Four Falsified or Adulterated Medicines

13 ARTICLES

2w ago

FDA Elevates Inventia Chlorthalidone Recall to Class II After Failed Dissolution Tests

8 ARTICLES

2w ago

AstraZeneca Buys Stake in Summit to Pursue Cancer Drug Combinations

6 ARTICLES

2w ago

Kodiak Drugs Clear Phase 3 for Wet AMD and Shares Soar

6 ARTICLES

2w ago

FDA Approves Juvmo as First D1/D5 Agonist for Parkinson’s Disease

3 ARTICLES

2w ago

Pharmaceuticals

INmune Bio and Quantum Computing Inc. Team Up to Run XPro Data Through a Quantum Optimizer

Amazon-Brand Acetaminophen Recalled After Reports of Discolored Tablets

Cochrane Review Finds Pharma Gifts and Payments Drive More and Less Appropriate Prescribing

Kagan and Soai Win 2026 Nobel Prize in Chemistry

FDA Lists Nine Eye-Care Products in Recall Over Sterility Concerns

FDA Approves Pirtobrutinib for Frontline Treatment of CLL and SLL

Controlled Study Finds Higher Rates of Nail Detachment and Hair Loss in GLP‑1 Users

AstraZeneca, Daiichi Sankyo and Summit Launch Global Trials of Datroway With Ivonescimab

Journal Review Highlights Ecopipam as a Non‑Antipsychotic Option for Pediatric Tourette

Postpartum GLP‑1 Starts Surge in U.S., Rising More Than 20‑Fold by Early 2025

Never miss stories about

Pharmaceuticals

Sanofi Expands Regeneron Collaboration With $1 Billion Upfront for Four Antibody Programs

Retatrutide Drives Record Weight Loss in Type 2 Diabetes, Company Moves Toward U.S. Filing

Orforglipron Found Noninferior to Insulin Glargine for Major Heart Events

U.S. Spending on GLP‑1 Drugs Rises to $64.9 Billion as Patient Costs Bite

Cofepris Issues Alert for Four Falsified or Adulterated Medicines

FDA Elevates Inventia Chlorthalidone Recall to Class II After Failed Dissolution Tests

AstraZeneca Buys Stake in Summit to Pursue Cancer Drug Combinations

Kodiak Drugs Clear Phase 3 for Wet AMD and Shares Soar

FDA Approves Juvmo as First D1/D5 Agonist for Parkinson’s Disease

Lilly’s Foundayo Wins Early Market Share as Company Moves to Scale Production

Never miss stories about

Pharmaceuticals